GGrantIndex
← Search

Bcl-2 proteins-targets for chemoprevention /Chemotherapy

$95,500R03FY2004CANIH

Burnham Institute For Medical Research, La Jolla CA

Investigators

Linked publications & trials

Abstract

DESCRIPTION (provided by applicant): The rationale for this proposal is based, in large measure, upon our recent exciting studies that show that selected polyphenols, including extracts from black and green tea, may be inducing apoptosis (programmed cell-death) by targeting proteins of the Bcl-2 family. Bcl-2 and Bcl-x L are over-expressed in approximately 70% of prostate and breast cancers, preventing cancer cells from dying despite radiation and chemotherapy. As such, it is reasonable to hypothesize that dietary compounds capable to neutralize the protective effects of Bcl-2 family proteins in vitro may possess chemopreventive activity in vivo. On the premises, we propose to use biophysical assays to screen large libraries of natural dietary compounds for inhibition of Bcl-x L and Bcl-2 proteins and to study the cytotoxic effects of such compounds on human cancer cell lines. We anticipate that promising pro-apoptotic compounds would arise from our studies and that such dietary substances would have an impact not only in cancer chemoprevention but also in the development of new clinical therapies for the treatment of cancer.

View original record on NIH RePORTER →